155 related articles for article (PubMed ID: 15859906)
21. Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration rates.
Lim WH; Chang SH; Coates PT; McDonald SP
Transplantation; 2007 Oct; 84(8):972-80. PubMed ID: 17989602
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
Stratta RJ; Alloway RR; Lo A; Hodge EE
Transplant Proc; 2005 Oct; 37(8):3527-30. PubMed ID: 16298650
[TBL] [Abstract][Full Text] [Related]
23. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
[TBL] [Abstract][Full Text] [Related]
24. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
25. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
26. Infection related renal impairment: a major cause of acute allograft dysfunction.
Nampoory MR; Johny KV; Costandy JN; Nair MP; Said T; Homoud H; Al-Muzairai I; Samhan M; Al-Moussawi M
Exp Clin Transplant; 2003 Jun; 1(1):60-4. PubMed ID: 15859909
[TBL] [Abstract][Full Text] [Related]
27. Mycobacterium tuberculosis infection following renal transplantation in Taiwan.
Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH
Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973
[TBL] [Abstract][Full Text] [Related]
28. Noncompliance in children with renal transplants.
Korsch BM; Fine RN; Negrete VF
Pediatrics; 1978 Jun; 61(6):872-6. PubMed ID: 353683
[TBL] [Abstract][Full Text] [Related]
29. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
Manga Sahin G; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
[TBL] [Abstract][Full Text] [Related]
30. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
Lisik W; Schoenberg L; Lasky RE; Kahan BD
Transplant Proc; 2007 Dec; 39(10):3086-92. PubMed ID: 18089328
[TBL] [Abstract][Full Text] [Related]
31. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
Morris JA; Hanson JE; Steffen BJ; Chu AH; Chi-Burris KS; Gotz VP; Gordon RD
Clin Transplant; 2005 Jun; 19(3):340-5. PubMed ID: 15877795
[TBL] [Abstract][Full Text] [Related]
32. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
Wang D; Wu WZ; Yang SL; Chen JH; Tan JM
Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
[TBL] [Abstract][Full Text] [Related]
35. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.
Corman SL; Coley KC; Schonder KS
Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653
[TBL] [Abstract][Full Text] [Related]
36. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
37. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis.
Arness T; Pedersen R; Dierkhising R; Kremers W; Patel R
Transpl Infect Dis; 2008 Jul; 10(4):260-8. PubMed ID: 18086277
[TBL] [Abstract][Full Text] [Related]
38. Incidence of acute renal transplant rejection in atopic individuals.
Seung LM; Lorincz AL
Arch Dermatol; 1994 May; 130(5):584-8. PubMed ID: 8179340
[TBL] [Abstract][Full Text] [Related]
39. Noncompliance in organ transplant recipients.
Swanson MA; Palmeri D; Vossler ED; Bartus SA; Hull D; Schweizer RT
Pharmacotherapy; 1991; 11(6):173S-174S. PubMed ID: 1771143
[TBL] [Abstract][Full Text] [Related]
40. Noncompliance in organ transplant recipients.
Rovelli M; Palmeri D; Vossler E; Bartus S; Hull D; Schweizer R
Transplant Proc; 1989 Feb; 21(1 Pt 1):833-4. PubMed ID: 2650282
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
